<DOC>
	<DOCNO>NCT02166060</DOCNO>
	<brief_summary>The purpose study determine role ivabradine cardiac resynchronization recipient unsatisfactory percentage biventricular pacing . The study protocol 60 patient heart failure NYHA ( New York Heart Association ) II-IV treat optimal medical therapy clinically indicate receive CRT-D device 3 month ago . Patients biventricular pace &lt; 95 % heart rate &lt; 70 rest &gt; 50 % heart rate device memory &gt; 70 receive ivabradine . The minimal follow-up patient study least six month .</brief_summary>
	<brief_title>Ivabradine Patients With Unsatisfactory Percentage Cardiac Resynchronization Therapy</brief_title>
	<detailed_description>Approximately 30 % CRT recipients respond therapy . One cause ot unsatisfactory percentage biventricular pacing . Patients may loose biventricular pace inadequate sinus tachycardia . Ivabradine may prevent inadequate sinus tachycardia improve quality live CRT recipient . According current guideline ivabradine recommend patient symptomatic heart failure heart rate rest &gt; 70 . The hypothesis study ivabradine may increase percentage biventricular pacing CRT recipients unsatisfactory percentage biventricular pace &gt; 50 % heart rate device memory &gt; 70 .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>heart failure NYHA IIIV leave ventricular ejection fraction = &lt; 35 % CRTD implant 3 month ago optimal CRTD parameter biventricular pace &lt; 95 % despite optimal parameter device optimal pharmacotherapy high welltolerated betaadrenolytic dosage heart rate rest 70 bpm 50 % heart rhythm 70 bpm interrogation device persistent atrial fibrillation/flutter device associate ineffective resynchronization contraindication ivabradine</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>